A new study has found that the clot-dissolving drug alteplase can significantly improve stroke recovery even when given up to ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those ...

Long-term dual antiplatelet therapy has not been rigorously assessed in patients with specific ischemic stroke subtypes other than that associated with atrial fibrillation (JW Neurol Aug 11 2009).

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

Alteplase improves stroke recovery by over 50% when given up to 24 hours after symptom onset, offering hope for patients with ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

The study results show promise to patients suffering from stroke worldwide, who may not be able to access clot-dissolving ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

The University of Cincinnati's Pooja Khatri spoke with Medscape on a new American Heart Association advisory recommending endovascular therapy (EVT) as a treatment for patients with large-core ...

The benefit of direct oral anticoagulants on stroke risk in patients with prior intracerebral hemorrhage and atrial ...

Other research has indicated it may also work well in some patients 4.5 to 9 hours after stroke onset. The American Heart Association ... that could recover with treatment. Participants were ...